您当前的位置:国际号刊-季刊 > 化学 >
绿色合成与催化(英文)(Green Synthesis and Catalysis)(国际刊号)

绿色合成与催化(英文)(Green Synthesis and Catalysis)(国际刊号)

基本信息
  • 主管单位:

  • 主办单位:

    复旦大学、武汉工程大学

  • 国际刊号:

    : 2666-5549

  • 国内刊号:

  • 学科分类:

    化学

  • 字数:

    8000-26000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    国际号刊-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

    010-63011632(郭焕芳教授)(官网电话)

  • 邮箱:

    GSC_fudan@fudan.edu.cn(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

  • 级别:

期刊简介

《绿色合成与催化(英文)(Green Synthesis and Catalysis)(国际刊号)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、该刊只有国际刊号。

2、投稿方式:在线投稿。

3、官网网址:

http://www.keaipublishing.com/en/journals/green-synthesis-and-catalysis/

https://www.sciencedirect.com/journal/green-synthesis-and-catalysis

4、投稿系统:

https://www.editorialmanager.com/gresc/default.aspx

5、官网邮箱:GSC_fudan@fudan.edu.cn(编辑部)

6、官网电话:010-63011632(郭焕芳教授)

7、出刊日期:季刊,逢季中月出版。

2021年9月29日星期三

《绿色合成与催化(英文)》期刊简介

(Green Synthesis and Catalysis)

Green Synthesis and Catalysis (GSC) 由复旦大学和武汉工程大学主办,由KeAi出版,利用Elsevier国际化出版平台ScienceDirect,发表一流绿色化学领域的最新研究成果,搭建一流研究成果发布平台,致力于成为绿色合成领域的主流期刊。

★Aims and Scope

GSC is dedicated to publishing high-impact research discoveries and results from academic and industrial laboratories on sustainable synthetic technologies for molecule construction and production. The journal features content that is related to homogeneous and heterogeneous catalysis, including organometallics, metal-complex catalysis, organocatalysis, photocatalysis, and biocatalysis, and synthetic technologies such as synthesis design, reaction techniques, flow chemistry and continuous processing, multiphase catalysis, green reagents and solvents, catalyst immobilization and recycling, biotechnology, and separation science and process development.

期刊主页:

http://www.keaipublishing.com/GRESC

主编

陈芬儿

中国工程院院士,复旦大学教授

王卫

亚利桑那大学教授

《绿色合成与催化(英文)》作者指南

(Green Synthesis and Catalysis)

【官网信息】

Guide for Authors

INTRODUCTION

Types of papers

Contributions falling into the following categories will be considered for publication: Papers reporting original research, Reviews, Letters to the editor, Opinion papers, commentary, and others deemed appropriate.

Authors should ensure to select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.

BEFORE YOU BEGIN

Ethics in publishing

For information on Ethics in Publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines.

For information on Ethics in Publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines.

Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect instances of overlapping and similar text in submitted manuscripts. Details can be found here https://www.elsevier.com/editors/perk/plagiarism-complaints/plagiarism-detection.

Declaration of competing interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More information.

Submission declaration

Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Changes to authorship

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:

Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.

After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

Changes to authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.

Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

……

更多详情:

http://www.keaipublishing.com/en/journals/green-synthesis-and-catalysis/guide-for-authors/

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。